Electric Countershock (Cardioversion)

Subscribe to Selected New Research on Electric Countershock

2486 relevant articles (204 outcomes, 381 trials/studies) found for this Therapy

Description: An electrical current applied to the HEART to terminate a disturbance of its rhythm, ARRHYTHMIAS, CARDIAC. (Stedman, 25th ed)

Also Known As:

Cardioversion; Electroversion Therapy; Therapy, Electroversion; Cardiac Electroversions; Cardioversions; Countershock, Electric; Countershocks, Electric; Defibrillations, Electric; Electric Countershocks; Electric Defibrillation; Electric Defibrillations; Electroversion Therapies; Electroversions, Cardiac; Therapies, Electroversion; Cardiac Electroversion; Defibrillation, Electric; Electroversion, Cardiac

Relationship Network

Therapy Context: Research Results

Therapeutics: 5221

Electric Stimulation Therapy: 286

Electric Countershock: 2486

Experts

1.	Opolski, Grzegorz: 12 articles (11/2006 - 05/2002)
2.	Klein, Allan L: 11 articles (10/2008 - 09/2002)
3.	Malouf, Joseph F: 10 articles (10/2008 - 11/2002)
4.	Crijns, Harry J G M: 10 articles (10/2006 - 08/2002)
5.	Van Gelder, Isabelle C: 10 articles (10/2006 - 08/2002)
6.	Lieber, Elizabeth A: 8 articles (10/2008 - 07/2003)
7.	Jasper, Susan E: 8 articles (10/2008 - 07/2003)
8.	Ammash, Naser M: 8 articles (07/2008 - 11/2002)
9.	Friedman, Paul A: 8 articles (07/2008 - 11/2002)
10.	Van Veldhuisen, Dirk J: 8 articles (10/2006 - 09/2004)

Related Diseases

1.	Atrial Fibrillation 10/01/1996 - "BACKGROUND: Previous studies in patients with atrial fibrillation undergoing intracardiac cardioversion have suggested that intracardiac cardioversion is highly effective and safe" 04/14/2006 - "BACKGROUNDS: Cardioversion for atrial fibrillation (AF) is the most effective treatment for the restoration of sinus rhythm (SR)" 07/01/2005 - "CONCLUSION: For refractory atrial fibrillation to conventional cardioversion double sequential transthoracic shocks represents a safe and highly efficacious alternative and may have a general applicability." 02/01/1999 - "BACKGROUND AND OBJECTIVE: Although external electrical cardioversion is effective in most patients with atrial fibrillation, there are cases refractory to external cardioversion" 12/01/2007 - "Rectilinear biphasic cardioversion (Bi-DC) has been shown to be very effective for restoration of sinus rhythm in patients with persistent atrial fibrillation (AF)" Order ALL the reference details at left...
2.	Atrial Flutter (Flutter, Atrial) 01/01/1997 - "CONCLUSIONS: Electrical cardioversion was an effective and safe method of converting chronic atrial flutter to sinus rhythm" 03/01/2006 - "The efficacy of biphasic waveform cardioversion of atrial flutter in pediatric patients has not previously been demonstrated" 03/01/2006 - "Efficacy of biphasic waveform compared to monophasic waveform for cardioversion of atrial flutter in pediatric patients." 03/01/1999 - "BACKGROUND: Direct-current cardioversion remains the gold standard for restoration of sinus rhythm in patients with atrial flutter" 06/01/1993 - "OBJECTIVE--To compare the safety and efficacy of transoesophageal atrial pacing (TAP) with an easily swallowed pill electrode and direct current cardioversion (DCC) in patients with atrial flutter that was refractory to appropriate medical treatment" Order ALL the reference details at left...
3.	Shock 09/01/2001 - "Quadruple pads external cardioversion is highly effective in converting chronic AF refractory to standard shock protocols to sinus rhythm" 01/01/2000 - "Electrical transthoracic cardioversion by using different electrode positions and additional pressure over the electrodes during shock delivery is a highly effective and well-tolerated method in restoration of sinus rhythm even in patients under conscious sedation" 11/01/2004 - "The results indicate that higher energy DC shock application using a double external defibrillator is an effective and safe method for the cardioversion of refractory AF" 01/01/1976 - "The efficacy of DC shock and the maintenance of sinus rhythm after cardioversion was greater in patients with AF having a slower rate and a longer MAP." 12/01/2005 - "CONCLUSION: A strategy of approximately 24-hour delay in cardioversion shock timing decreased the incidence of ERAF, relative to a shock delivered within a few hours of AF onset" Order ALL the reference details at left...
4.	Tachycardia (Tachyarrhythmias) 01/20/1993 - "11 out of 17 patients (65%) experienced one or more episodes of tachyarrhythmias which was treated successfully with overdrive pacing (ramp or burst), cardioversion or defibrillation" 02/01/1978 - "In a large number of cases, electrotherapeutical approaches such as DC-cardioversion and cardiac pacing are effective in controlling ectopic tachycardias" 11/01/1993 - "A tachycardia-related efficacy of 69% and patient-related efficacy of 46% of the low-energy cardioversion < or = 4 joules was observed" 09/01/2006 - "Serum cardiac markers response to biphasic and monophasic electrical cardioversion for supraventricular tachyarrhythmia--a randomised study." 11/01/2003 - "The study population consisted of 22 patients who developed supraventricular tachyarrhythmias after transthoracic cardioversion (300 J) delivered to stop a VT or VF induced by electrophysiological study" Order ALL the reference details at left...
5.	Cardiac Arrhythmias (Arrythmia) 04/01/2000 - "At 1 month follow-up, the percentage of arrhythmia relapses in patients with initially successful cardioversion was similar in the two groups (29% vs 26%, P = ns); thus the initial better outcome in patients with recent-onset arrhythmia was not lost" 04/01/1994 - "Use of pacing includes several advantages, but it is not always effective; when pacing is not effective, shocks can be used for cardioversion of the arrhythmia" 05/01/1984 - "The arrhythmia was resistant to multiple drugs, and repeated cardioversion was effective in only 3 patients" 01/01/2000 - "External electrical cardioversion has been a remarkably effective and safe method for termination of this arrhythmia" 06/01/1998 - "External electrical cardioversion has been a remarkably effective and safe method for termination of this arrhythmia" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Amiodarone (Amiodarona)
2.	ibutilide (Corvert)
3.	Flecainide (Tambocor)
4.	Verapamil (Calan)
5.	Anti-Arrhythmia Agents
6.	Quinidine (Chinidin)
7.	Sotalol (Sotalol Hydrochloride)
8.	Enoxaparin (Lovenox)
9.	dronedarone
10.	Propafenone (Rythmol)

Related Therapies and Procedures

1.	Electrodes (Electrode)
2.	Defibrillators (Defibrillator)
3.	Drug Therapy (Chemotherapy)
4.	Cardiopulmonary Resuscitation (CPR)
5.	Conscious Sedation

Best Treatments:
Research Summary Report
on Atrial Fibrillation

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 809 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>